Key Takeaways Strategic developments in CDMO and semiconductor segments are set to drive significant revenue growth through innovative technology and market expansion. Operational efficiencies and a strong focus on advanced pharmaceutical intermediates are enhancing margins and sustaining long-term earnings growth.Read more
Catalysts About Acutaas Chemicals Acutaas Chemicals operates across pharmaceutical intermediates, contract development and manufacturing, battery chemicals, semiconductor chemicals and other specialty chemical segments. What are the underlying business or industry changes driving this perspective?Read more
Catalysts About Acutaas Chemicals Acutaas Chemicals is a diversified global chemical company focused on advanced pharmaceutical intermediates, CDMO services, and high value specialty chemicals, including battery and semiconductor chemistries. What are the underlying business or industry changes driving this perspective?Read more
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications. It also provides specialty chemicals for use in battery chemicals, personal care, agrochemicals, coatings, electronics, and industrial processes; photoresist chemicals to semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.
